Cargando…

Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran

Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajami, Gholamhossein, Aflaki, Khashayar, Alyasin, Soheila, Gharesi-fard, Behrooz, Borzouee, Mohammad, Amoozgar, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339557/
https://www.ncbi.nlm.nih.gov/pubmed/25755855
_version_ 1782358880817250304
author Ajami, Gholamhossein
Aflaki, Khashayar
Alyasin, Soheila
Gharesi-fard, Behrooz
Borzouee, Mohammad
Amoozgar, Hamid
author_facet Ajami, Gholamhossein
Aflaki, Khashayar
Alyasin, Soheila
Gharesi-fard, Behrooz
Borzouee, Mohammad
Amoozgar, Hamid
author_sort Ajami, Gholamhossein
collection PubMed
description Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease. Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control. Findings : While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40(*), there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significant Conclusion: The presence of higher frequency of allele type-B40(*) in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area.
format Online
Article
Text
id pubmed-4339557
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-43395572015-03-09 Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran Ajami, Gholamhossein Aflaki, Khashayar Alyasin, Soheila Gharesi-fard, Behrooz Borzouee, Mohammad Amoozgar, Hamid Iran J Pediatr Original Article Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease. Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control. Findings : While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40(*), there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significant Conclusion: The presence of higher frequency of allele type-B40(*) in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area. Tehran University of Medical Sciences 2014-08 2014-05-24 /pmc/articles/PMC4339557/ /pubmed/25755855 Text en Copyright © 2014 by Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, All rights reserved This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ajami, Gholamhossein
Aflaki, Khashayar
Alyasin, Soheila
Gharesi-fard, Behrooz
Borzouee, Mohammad
Amoozgar, Hamid
Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title_full Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title_fullStr Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title_full_unstemmed Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title_short Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
title_sort distribution and protective role of hlab40 in iranian patients with kawasaki disease; a report from southern iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339557/
https://www.ncbi.nlm.nih.gov/pubmed/25755855
work_keys_str_mv AT ajamigholamhossein distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran
AT aflakikhashayar distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran
AT alyasinsoheila distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran
AT gharesifardbehrooz distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran
AT borzoueemohammad distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran
AT amoozgarhamid distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran